 | Arcutis Biotherapeutics, Inc. | |||
| NMS : ARQT || Location: United States | ||||
$9.23-0.22 (-2.38%) |
0.78 M | 8.92 - 9.45 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 19.257 M |
| March 15, 2024 | 14.993 M |
| Feb. 29, 2024 | 15.782 M |
| Feb. 15, 2024 | 16.942 M |
| Jan. 31, 2024 | 16.778 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.79 | -0.72 | 8.92% |
| 09/30/2023 | -0.87 | -0.73 | 16.54% |
| 06/30/2023 | -1.28 | -1.16 | 9.03% |
| 03/31/2023 | -1.31 | -1.31 | 0.03% |
| 12/31/2022 | -1.45 | -1.18 | 18.71% |
ARQT Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 114.971M | Shares Float | 74.791M |
| Short Float | 19.257M | Market Cap | 1086.48M |
| Institution ownership | 95.84% | Insider ownership | 2.496% |
| Earnings Date | 05/01/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -3.78 | Forward EPS | -1.46 |